Whither TSH receptor blocking antibodies in the treatment of Graves' disease?

Thyroid

Volumn 18, Issue 7, 2008, Pages 695-696

  Rapoport, Basil ^a   McLachlan, Sandra M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD20 ANTIBODY; ENDOTHELIAL CELL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 5C9; MONOCLONAL ANTIBODY CS 17; THIONAMIDE; THYROGLOBULIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADIPOGENESIS; CHEMICAL STRUCTURE; DRUG ACTIVITY; DRUG BINDING; DRUG MECHANISM; EDITORIAL; ENDOCRINE OPHTHALMOPATHY; GRAVES DISEASE; HUMAN; HYPOTHYROIDISM; IMMUNOGENICITY; NONHUMAN; PRIORITY JOURNAL; UNSPECIFIED SIDE EFFECT;

ANTIBODIES, MONOCLONAL; GRAVES DISEASE; HUMANS; RECEPTORS, THYROTROPIN;

EID: 47549110177     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2008.0140     Document Type: Editorial

References (15)

1. Nielsen CH, El Fassi D, Hasselbalch HC, Bendtzen K, Hegedus L 2007 B-cell depletion with rituximab in the treatment of autoimmune diseases. Graves' ophthalmopathy the latest addition to an expanding family. Expert Opin Biol Ther 7:1061-1078.
2. Lanzavecchia A 1985 Antigen-specific interaction between T and B cells. Nature 314:537-539.
3. Dai Y, Carayanniotis KA, Eliades P, Lymberi P, Shepherd P, Kong Y, Carayanniotis G 1999 Enhancing or suppressive effects of antibodies on processing of a pathogenic T cell epitope in thyroglobulin. J Immunol 162:6987-6992.
4. Guo J, Quaratino S, Jaume JC, Costante G, Londei M, McLachlan SM, Rapoport B 1996 Autoantibody-mediated capture and presentation of autoantigen to T cells via the Fc epsilon receptor by a recombinant human autoantibody Fab converted to IgE. J Immunol Methods 195:81-92.
5. McLachlan SM, Rapoport B 2004 Why measure thyroglobulin autoantibodies rather than thyroid peroxidase autoantibodies? Thyroid 14:510-520.
6. McLachlan SM, Rapoport B 2007 Thyroid peroxidase as an autoantigen. Thyroid 17:939-948.
7. Sanders J, Evans M, Premawardhana LD, Depraetere H, Jeffreys J, Richards T, Furmaniak J, Rees SB 2003 Human monoclonal thyroid stimulating autoantibody. Lancet 362:126-128.
8. Sanders J, Evans M, Betterle C, Sanders P, Bhardwaja A, Young S, Roberts E, Wilmot J, Richards T, Kiddie A, Small K, Platt H, Summerhayes S, Harris R, Reeve M, Coco G, Zanchetta R, Chen S, Furmaniak J, Rees Smith B 2008 A human monoclonal autoantibody to the thyrotropin receptor with thyroid stimulating blocking activity. Thyroid 18:735-746.
9. Smith BR, Sanders J, Furmaniak J 2007 TSH receptor antibodies. Thyroid 17:923-938.
10. Nagayama Y, Rapoport B 1992 Thyroid stimulatory autoantibodies in different patients with autoimmune thyroid disease do not all recognize the same components of the human thyrotropin receptor: selective role of receptor amino acids Ser25-Glu30. J Clin Endocrinol Metab 75:1425-1430.
11. Chazenbalk GD, Latrofa F, McLachlan SM, Rapoport B 2004 Thyroid stimulation does not require antibodies with identical epitopes but does involve recognition of a critical conformation at the N-terminus of the thyrotropin receptor A-subunit. J Clin Endocrinol Metab 89:1788-1793.
12. Sanders J, Chirgadze DY, Sanders P, Baker S, Sullivan A, Bhardwaja A, Bolton J, Reeve M, Nakatake N, Evans M, Richards T, Powell M, Miguel RN, Blundell TL, Furmaniak J, Smith BR 2007 Crystal structure of the TSH receptor in complex with a thyroid-stimulating autoantibody. Thyroid 17:395-410.
13. Chen CR, McLachlan SM, Rapoport B 2007 Suppression of thyrotropin receptor constitutive activity by a monoclonal antibody with inverse agonist activity. Endocrinology 148:2375-2382.
14. Bahn RS 2003 Clinical review 157: pathophysiology of Graves' ophthalmopathy: the cycle of disease. J Clin Endocrinol Metab 88:1939-1946.
15. Khoo TK, Bahn RS 2007 Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies. Thyroid 17:1013-1018.